CUNY Graduate School of Public Health and Health Policy, Department of Epidemiology and Biostatistics, 55 W 125th St., New York, NY, 10027, USA.
CUNY Queens College, Department of Psychology, 65-30 Kissena Blvd, Flushing, NY, 11367, USA.
J Abnorm Child Psychol. 2020 Jun;48(6):783-795. doi: 10.1007/s10802-020-00632-9.
Exposure to prenatal stress increases offspring risk for long-term neurobehavioral impairments and psychopathology, such as Attention Deficit Hyperactivity Disorder (ADHD). Epigenetic regulation of glucocorticoid pathway genes may be a potential underlying mechanism by which maternal conditions 'program' the fetal brain for downstream vulnerabilities. The present study aims to investigate whether mRNA expression of glucocorticoid pathway genes in the placenta predict offspring negative affect during early childhood (between 6 and 24 months). Participants include 318 mother-child dyads participating in a longitudinal birth cohort study. Placental mRNA expression of glucocorticoid pathway genes (HSD11B1, HSD11B2, NR3C1, NCOR2) were profiled and negative affect traits of the offspring were measured at 6, 12, 18, and 24 months. HSD11B1 mRNA expression significantly predicted negative affect (β = -.09, SE = .04; p = .036), and Distress to Limitations trajectories (β = -.13, SE = .06; p = .016). NCOR2 mRNA expression significantly predicted Distress to Limitations (β = .43, SE = .21; p = .047), and marginally predicted Sadness trajectories (β = .39, SE = .21; p = .068). HSD11B2 and NR3C1 did not predict trajectories of Negative Affect or subscale scores. Infant negative affect traits were assessed via maternal self-report, and deviated from linearity across follow-up. mRNA expression of glucocorticoid pathway genes in the placenta may be a potentially novel tool for early identification of infants at greater risk for elevated negative affect. Further study is needed to validate the utility of mRNA expression of glucocorticoid pathway genes in the placenta.
产前应激会增加后代出现长期神经行为障碍和精神病理学的风险,例如注意力缺陷多动障碍(ADHD)。糖皮质激素通路基因的表观遗传调控可能是母体状况为胎儿大脑“编程”以应对下游脆弱性的潜在机制。本研究旨在探讨胎盘糖皮质激素通路基因的 mRNA 表达是否可预测后代在幼儿期(6 至 24 个月之间)的负性情绪。参与者包括 318 对参与纵向出生队列研究的母婴对子。分析了胎盘糖皮质激素通路基因(HSD11B1、HSD11B2、NR3C1、NCOR2)的 mRNA 表达,并在 6、12、18 和 24 个月时测量了后代的负性情绪特征。HSD11B1mRNA 表达显著预测了负性情绪(β=-0.09,SE=0.04;p=0.036)和限制性困扰轨迹(β=-0.13,SE=0.06;p=0.016)。NCOR2mRNA 表达显著预测了限制性困扰(β=0.43,SE=0.21;p=0.047),且勉强预测了悲伤轨迹(β=0.39,SE=0.21;p=0.068)。HSD11B2 和 NR3C1 均未预测负性情绪或子量表评分的轨迹。通过母亲的自我报告评估了婴儿的负性情绪特征,且在随访过程中偏离了线性。胎盘糖皮质激素通路基因的 mRNA 表达可能是一种早期识别高负性情绪风险增加的婴儿的潜在新工具。需要进一步的研究来验证胎盘糖皮质激素通路基因 mRNA 表达的效用。